Dolutegravir 50mg tablets
NHS hospitals in England used £75,444,022 of indicative cost of Dolutegravir 50mg tablets in the 12 months to April 2026, about 0.3% of all hospital medicines spend. That is up 3.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Dolutegravir 50mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Dolutegravir 50mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Chelsea & Westminster Hospital Nhs Ft | £7,029,878 |
| Imperial College Healthcare Nhs Trust | £4,014,560 |
| Manchester University Nhs Ft | £3,781,920 |
| Guy's & St Thomas' Nhs Foundation Trust | £3,209,617 |
| Leeds Teaching Hpls Nhs Trust | £3,172,022 |
| Univ Hpl B/Ham Nhs Foundation Trust | £2,629,159 |
| Barts Health Nhs Trust | £2,606,827 |
| Royal Free London Nhs Foundation Trust | £2,433,532 |
| Lewisham And Greenwich Nhs Trust | £2,235,908 |
| University College London Foundation Tr | £2,066,844 |
The primary-care picture
Dolutegravir is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Dolutegravir medicine page.